These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6654793)

  • 41. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
    Ciopor M; Fischer A; Turina J; Hess OM
    Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hemodynamic effects of combined isosorbide dinitrate-nifedipine therapy in congestive heart failure (author's transl)].
    Matsui S; Murakami E; Takekoshi N; Murakami H; Masuya K; Nomura M; Fujita S; Tsuji S; Chadani T
    Kokyu To Junkan; 1981 Sep; 29(9):965-70. PubMed ID: 7323483
    [No Abstract]   [Full Text] [Related]  

  • 43. The Vasodilator-Heart Failure Trials (V-HeFT). Mechanistic data from the VA Cooperative Studies. Introduction.
    Cohn JN
    Circulation; 1993 Jun; 87(6 Suppl):VI1-4. PubMed ID: 8500232
    [No Abstract]   [Full Text] [Related]  

  • 44. [Ambulatory treatment of chronic heart failure with peripheral vasodilators].
    Solonovich TG
    Kardiologiia; 1984 Nov; 24(11):113-4. PubMed ID: 6441064
    [No Abstract]   [Full Text] [Related]  

  • 45. Prevention of nitrate tolerance with concomitant administration of hydralazine.
    Elkayam U
    Can J Cardiol; 1996 May; 12 Suppl C():17C-21C. PubMed ID: 8634919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Modern vasodilator medication in refractory cardiac insufficiency].
    Stanciu L; Branea I; Riviş I; Radivoievici A; Mancaş S; Păunescu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(2):129-34. PubMed ID: 6139858
    [No Abstract]   [Full Text] [Related]  

  • 47. Indications for acute and chronic digitalis administration in heart failure.
    Gheorghiade M
    Henry Ford Hosp Med J; 1986; 34(3):178-83. PubMed ID: 3804774
    [No Abstract]   [Full Text] [Related]  

  • 48. Isosorbide dinitrate spray as therapeutic strategy for treatment of chronic venous ulcers.
    Sánchez-Vázquez R; Briseño-Rodríguez G; Cardona-Muñoz EG; Gálvez-Gastélum FJ; Totsuka-Sutto SE; Garcia-Benavides L
    Angiology; 2008; 59(1):64-71. PubMed ID: 18319224
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Vasodilator therapy by isosorbide dinitrate for the patients with congestive heart failure (author's transl)].
    Ogasawara B; Kai I; Kondo T; Watanabe E; Okubo M; Sassa H; Niwa T; Matsui E
    Nihon Naika Gakkai Zasshi; 1978 Jan; 67(1):24-34. PubMed ID: 632635
    [No Abstract]   [Full Text] [Related]  

  • 50. [Use of the vasodilator nitrosorbide in the treatment of chronic heart failure].
    Mareev VIu; Grigor'iants RA; Lobova NM; Naumov VG
    Sov Med; 1983; (1):70-4. PubMed ID: 6836396
    [No Abstract]   [Full Text] [Related]  

  • 51. Fixed combination isosorbide dinitrate-hydralazine for nitric-oxide-enhancing therapy in heart failure.
    Franciosa JA
    Expert Opin Pharmacother; 2006 Dec; 7(18):2521-31. PubMed ID: 17150006
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
    Kośmicki M; Szwed H; Kowalik I; Sadowski Z
    Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bi treatment with hydralazine/nitrates vs. placebo in Africans admitted with acute HEart Failure (BA-HEF).
    Sliwa K; Damasceno A; Davison BA; Mayosi BM; Sani MU; Ogah O; Mondo C; Ojji D; Dzudie A; Kouam CK; Yonga G; Ba SA; Ogola E; Edwards C; Milo O; Cotter G
    Eur J Heart Fail; 2016 Oct; 18(10):1248-1258. PubMed ID: 27206810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the effects of dopamine, hydralazine, and isosorbide dinitrate on myocardial hemodynamics in patients with refractory heart failure.
    Biddle TL; Moses HW
    J Clin Pharmacol; 1981; 21(8-9):343-50. PubMed ID: 7276228
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Combined use of isoprenaline and hydralazine in the treatment of chronic circulatory insufficiency].
    Krzyś T; Kalawski R; Flaczyński K; Lenartowicz I
    Wiad Lek; 1985 Jan; 38(2):97-101. PubMed ID: 4002707
    [No Abstract]   [Full Text] [Related]  

  • 56. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug.
    Straka RJ; Fish JT; Benson SR; Suh JT
    Pharmacotherapy; 1997; 17(1):126-32. PubMed ID: 9017773
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative efficacy of digoxin, hydralazine and combination therapy in chronic congestive heart failure.
    Patel HR; Thorat PB; Patel KH; Mehta NC; Shah CP
    J Assoc Physicians India; 1986 Jun; 34(6):422-4. PubMed ID: 3771482
    [No Abstract]   [Full Text] [Related]  

  • 59. Usefulness of Isosorbide Dinitrate and Hydralazine as add-on therapy in patients discharged for advanced decompensated heart failure.
    Mullens W; Abrahams Z; Francis GS; Sokos G; Starling RC; Young JB; Taylor DO; Tang WH
    Am J Cardiol; 2009 Apr; 103(8):1113-9. PubMed ID: 19361599
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The effect of a single administration of isosorbide dinitrate (Isoket ampules) in heart failure].
    Vítovec J; Roubalík P; Blaha M; Krifta P; Studeník P; Sobotová D; Stejfa M
    Vnitr Lek; 1988 Mar; 34(3):245-51. PubMed ID: 3369098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.